• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    Deep (Brain) Thoughts with Medtronic's Neuromodulation President

    Grab and Go: Examining the Thrombectomy Device Market

    Fine Print: A Discourse on Additive Manufacturing

    MPO's 2022 Medtech Industry Year in Review

    Micro Molding for Medtech Is Miniature Magic
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Medtech Makers
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Regulatory
    Financial/Business
    Top News
    Aspivix's Carevix Cervical Stabilizer Gains FDA OK

    Apyx Medical Submits 510(k) App for Renuvion APR Handpiece

    LivaNova Releases SenTiva DUO VNS for Drug-Resistant Epilepsy

    CGM Devices Could Become Main Glucose Monitoring Solution in U.S.

    New Device Developed to Non-Invasively Measure Cervical Nerve Activity
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    Deep (Brain) Thoughts with Medtronic's Neuromodulation President

    Grab and Go: Examining the Thrombectomy Device Market

    Fine Print: A Discourse on Additive Manufacturing

    MPO's 2022 Medtech Industry Year in Review

    Micro Molding for Medtech Is Miniature Magic
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    Reflections on 2022 and What’s Ahead for Medtech: MPO Sounding Board

    3 Ways to Prepare for ISO 13485/Part 820 Harmonization

    A New Home for Theranos' Elizabeth Holmes?

    Health Cost Drivers for Large Employers

    Braving Change: Facing Fears in the Midst of Major Transitions
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    Orthopedics
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    Fusion Biotec Inc.

    Arthur G. Russell Co. Inc., The

    JBC Technologies

    Forefront Medical Technology

    Halkey-Roberts Corporation
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    How Artificial Intelligence Can Combat Key Issues Impacting Healthcare

    Why Advanced Sensors Are Crucial Within Medical Pumps

    How Artificial Intelligence Could Help Prevent 80% of Chronic Diseases

    4 Ways to Use Injection Molding in Medical Device Manufacturing

    Telemedicine and Connectivity to Drive Material Innovation in the Near Future
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    Fusion Biotec Inc.

    Arthur G. Russell Co. Inc., The

    JBC Technologies

    Forefront Medical Technology

    Halkey-Roberts Corporation
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
      • Orthopedics
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • eBook
    • Resources
    • Podcasts
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Columns

    Four Considerations When Selling to a Private Equity Fund

    A private equity partner can help medtech firms expand into new markets and serve existing clients better.

    Related Content
    • LRE Medical GmbH
    • Northeast Biomedical Inc.
    • Nissha Medical Technologies
    • JK Medirise-Disposable Medical Device Company
    • Brosseau Consulting LLC
    Bill Hadler and Anisa Mohanty, McDermott Will & Emery04.01.21
    The benefits of selling to a private equity (PE) fund can extend well beyond the capital infusion. The right PE partner can equip an entrepreneurial medical product or device company with the expertise to expand into new markets and serve existing clients better. It can also help professionalize key corporate functions, such as finance and marketing, in order to take the company to the next level.

    Companies considering selling to a PE fund should follow these four steps to help minimize surprises and secure better outcomes.

    Step One: Conduct a Gap Analysis
    Many entrepreneurial medical device companies considering a PE investment have top-notch technology and strong revenue streams. Their corporate functions and regulatory strategy, however, may be somewhat sparse. Therefore, it is advisable to conduct a gap analysis using both external auditors and self-assessments to identify areas of weakness and potential risks. Knowing in advance which aspects of the business may need further investment and improvement will reduce the chance of mid-transaction surprises and make negotiations with a buyer more productive.

    The top priority for a gap analysis should be understanding exactly how the product or medical device is regulated, as potential enforcement exposure can be a major roadblock for a buyer. While a founder-entrepreneur may be comfortable with a certain degree of risk regarding regulatory grey areas, PE funds typically are not, since they are responsible to their institutional partners. An external regulatory consultant can help clarify the compliance obligations for a medical device or product. These consultants may have a long scheduling lead time, so plan well ahead.

    For facilities that are regulated by the U.S. Food and Drug Administration (FDA), it is wise to have an independent auditor conduct an assessment of quality control and operations in advance of any sale process. Similarly, fraud and abuse should be an audit focus if the customer base is highly regulated or if the product is a reimbursed medical device.

    Even if a company lacks the capital or lead time to rectify a regulatory or reimbursement problem prior to a sale, conversations with prospective buyers will be more productive if the issue can be competently discussed and a practical, financially sound solution identified. Understanding potential compliance weaknesses will also help avoid surprises regarding the purchase price, as expenses necessary to gain FDA clearance or obtain certifications may be taken out of the company’s valuation through add-backs.

    Intellectual property (IP) is another important element of a gap analysis. The transaction due diligence process will examine the protocols and systems for protecting IP, including issues of data security, so it’s helpful to know in advance what the IP portfolio looks like and how it is being protected. Contract manufacturing firms that don’t actually own the IP for the relevant medical device or product they help produce must still ensure they are protecting that property on their customers’ behalf.

    Step Two: Ensure Corporate Housekeeping Is in Good Order
    Companies with cutting-edge technology may still need to review and refresh their back-office marketing, finance, and accounting processes to maximize their value to potential buyers. Medtech firms should take a close look at staffing and training procedures. Are the finance and accounting functions communicating effectively? Do the individuals responsible for training have the right experience and expertise?

    Seemingly small housekeeping issues can have big consequences. An incomplete corporate reorganization or lack of communication between departments, for example, may lead to missed Internal Revenue Service filings and material tax exposure. While a PE fund can help professionalize corporate functions, it is far better to discover and resolve problems before the buyer is involved than to have them surface as an unpleasant surprise mid-transaction.

    Step Three: Pick the Right Partner
    When choosing a PE fund to which to sell, price is almost always the top factor. But other dynamics can help guide the decision as well. A partner that knows the sector well will not only be able to bring its own expertise to the table, but can engage experienced operating partners and outside directors to add value to a medtech company. The same goes for other external advisors: hire accountants, lawyers, and bankers that are deeply familiar with a particular industry and have experience with similar deals.

    A potential PE investor should have the right regulatory experience to support a company, and should have the capital for additional investments for growth subsequent to the deal. Most indications of interest will include references from other entrepreneurs who have sold to the PE fund. Talking to these references about their experience with the fund can help medtech executives evaluate whether it is a good fit for their organizations and products.

    Step Four: Set Expectations
    Particularly in today’s sellers’ market, with high multiples attached, PE funds often need to move aggressively to grow and lever up the purchased company. For medical product and device entrepreneurs or company founders used to managing their own business solo, the transition to working with an equity partner and responding to a board of directors can be jarring.

    Mentally preparing for this increased level of accountability and corporate cultural shift is an important step of the transaction process. Setting appropriate expectations in advance will help entrepreneurs transition smoothly into this next phase of their company’s growth and reap the benefits of a productive PE relationship for years to come. 


    Bill Hadler is a partner at McDermott Will & Emery. He counsels clients on mergers and acquisitions, private equity transactions, securities offerings and general corporate matters. Hadler has advised public and private companies, as well as private equity funds and their portfolio companies, in connection with mergers, acquisitions and divestitures across multiple industries, including healthcare, specialty retail, consumer products and financial services.

    Anisa Mohanty advises medical device, biotech and pharmaceutical companies on U.S. Food and Drug Administration premarket strategy and post-market compliance issues, from advertising and promotion to disclosure and periodic reporting. She offers guidance to her clients on the regulatory requirements and industry standards for the development, creation and review of advertising and promotional materials for drugs and medical devices.
    Suggested For You
    LRE Medical GmbH LRE Medical GmbH
    Northeast Biomedical Inc. Northeast Biomedical Inc.
    Nissha Medical Technologies Nissha Medical Technologies
    JK Medirise-Disposable Medical Device Company JK Medirise-Disposable Medical Device Company
    Brosseau Consulting LLC Brosseau Consulting LLC
    Oberg Medical Oberg Medical
    Lincotek Medical Lincotek Medical
    DDL Inc. DDL Inc.
    C&J Industries Inc. C&J Industries Inc.
    NDH Medical Inc. NDH Medical Inc.
    sfm medical devices GmbH sfm medical devices GmbH
    Teleflex Medical OEM Teleflex Medical OEM
    Simbex Simbex
    Dupaco Inc. Dupaco Inc.
    Coastline International Inc. Coastline International Inc.

    Related Buyers Guide Companies

    • LRE Medical GmbH

      ...
      Eva, Bardutzky 11.28.22

    • Northeast Biomedical Inc.

      ...
      Timothy Looney, Northeast Biomedical, Inc. 11.18.22

    • Nissha Medical Technologies

      ...
      Amy Jeary, Market Development Manager 11.18.22


    • JK Medirise-Disposable Medical Device Company

      ...
      Ketan Munjani, Marketing Manager 11.17.22

    • Brosseau Consulting LLC

      ...
      Bryan Brosseau, President & Principal Consultant 11.17.22

    Loading, Please Wait..

    Trending
    • Study: Smartphone Therapeutic Helps Improve Fibromyalgia In Patients
    • The Future Of Biomedical Engineering Advancements
    • Environmental Sustainability Becoming Increasingly Important To Medtech Industry
    • Medtronic's Recall Of Mahurkar Catheters Is Class I
    • A New Approach To Post-Market Surveillance
    Breaking News
    • Aspivix's Carevix Cervical Stabilizer Gains FDA OK
    • Apyx Medical Submits 510(k) App for Renuvion APR Handpiece
    • LivaNova Releases SenTiva DUO VNS for Drug-Resistant Epilepsy
    • CGM Devices Could Become Main Glucose Monitoring Solution in U.S.
    • New Device Developed to Non-Invasively Measure Cervical Nerve Activity
    View Breaking News >
    CURRENT ISSUE

    November 2022

    • MPO's 2022 Year in Review
    • Fine Print: A Discourse on Additive Manufacturing
    • Grab and Go: Examining the Thrombectomy Device Market
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    GOED Elects New Board Officers for 2023
    Aspire Hires Darrec Jones as VP of Business Development
    Pycnogenol Supplementation Linked to Better Hair Density in Menopausal Women
    Coatings World

    Latest Breaking News From Coatings World

    PPG Completes COLORFUL COMMUNITIES Project in Denmark
    10 Partners of the Automotive Industry Form JV, Cofinity-X
    BASF Recognized as Top Company for Supplier Diversity
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    Aspivix's Carevix Cervical Stabilizer Gains FDA OK
    Apyx Medical Submits 510(k) App for Renuvion APR Handpiece
    LivaNova Releases SenTiva DUO VNS for Drug-Resistant Epilepsy
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Bionova Expansion Project to Quadruple GMP Biologics Manufacturing Capacity
    Steriline Provides Fill-Finish Solution for Berkshire Sterile Manufacturing
    Merck Revenues up 22% for the Year to $59.3B
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Mielle Unveils Haircare Bundles Inspired by Amazon Original Series Harlem
    Kering Appoints Former L’Oréal and Estée Lauder Exec as CEO of Kering Beauté
    Paco Rabanne, Fashion & Perfume Designer, Dies
    Happi

    Latest Breaking News From Happi

    Sally Beauty Holdings Reports Net Sales of $957 Million in Q1 Results
    Murad and Active Minds To Combat Health Epidemic of Stress
    Elf Cosmetics Launches New O Face Satin Lipstick
    Ink World

    Latest Breaking News From Ink World

    Roland DGA Announces Key Changes to Leadership Team
    Ball Reports 2022 Results
    3D Printing Materials Market Worth $7.9 Billion by 2027: MarketsandMarkets
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Rotocon announces wine label design competition
    Cepi, EHPA partner for energy savings in paper manufacturing
    Brook + Whittle acquires LLT Labels
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Suominen Reports Q4, Full Year Results
    Qvin Menstrual Blood Diagnostic Device Receives FDA Approval in Thailand
    Andritz, KCF Technologies Form Agreement
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Toetal Solutions Secures $1.8 Million in New Financing
    Adrian Tyndall Joins Axogen's Board of Directors
    ADSM-Synchro Medical Acquired by Tyber Medical
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Zebra Provides East West Shrine Bowl with RFID Tracking Technology
    AAAS Elects Three ORNL Scientists as Fellows
    Flex Recognized as One of Fortune World’s Most Admired Companies 2023

    Copyright © 2023 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login